Clinical Laserthermia Systems invites investors, analysts and media to attend a Strategy Update Event on January 17, 2024 at 14.00-15.30 CET.

 

CLS AB is an innovative medical device company within healthcare technology and therapy. With people in mind, we are at the forefront of developing more precise, more effective interventional healthcare solutions.

 

Dan J. Mogren, CEO of CLS, and members from the management team will present the company’s strategic priorities and its commercial roll-out. The presentations will be held in English. Following the presentations, there will be a Q&A session moderated by Redeye analyst Gustaf Meyer. Viewers will have the opportunity to ask questions via the webcast chat.